Omnicare Reports Fourth-Quarter and Full-Year 2012 Financial Results; Company Provides Full-Year 2013 Guidance

Posted: Published on February 19th, 2013

This post was added by Dr P. Richardson

CINCINNATI, February 19, 2013 - Omnicare, Inc. (OCR) reported today financial results for its fourth quarter and full year ended December 31, 2012.

Fourth-Quarter Highlights:

Adjusted cash earnings per diluted share from continuing operations 10.3% higher to $0.86; GAAP earnings per diluted share of $0.54

Cash flows from continuing operations of $128 million

Full-Year Highlights:

Adjusted cash earnings per diluted share from continuing operations 15.9% higher to $3.36; GAAP earnings per diluted share of $1.73

Cash flows from continuing operations of $544 million

"We are pleased with our progress throughout 2012, in which we generated double-digit adjusted cash earnings per diluted share growth in every quarter," said John L. Workman, Omnicare`s Chief Executive Officer. "During the fourth quarter, we continued to leverage our scale position in our Long-Term Care Group to capitalize on the increased utilization of low-cost generic drugs, while also driving robust results within the manufacturer-focused platforms of our Specialty Care Group."

Fourth-Quarter Results

Financial results from continuing operations for the quarter ended December 31, 2012, as compared with the same prior-year period, were as follows:

More here:
Omnicare Reports Fourth-Quarter and Full-Year 2012 Financial Results; Company Provides Full-Year 2013 Guidance

Related Posts
This entry was posted in Wholesale Pharmacy. Bookmark the permalink.

Comments are closed.